X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ORCHID PHARMA LTD DR. DATSONS LABS/
ORCHID PHARMA LTD
 
P/E (TTM) x -10.9 -0.8 - View Chart
P/BV x 0.2 0.5 29.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ORCHID PHARMA LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ORCHID PHARMA LTD
Sep-13
DR. DATSONS LABS/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs126194 64.7%   
Low Rs3135 88.3%   
Sales per share (Unadj.) Rs133.0276.5 48.1%  
Earnings per share (Unadj.) Rs0.2-79.2 -0.2%  
Cash flow per share (Unadj.) Rs6.6-43.5 -15.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.853.9 238.8%  
Shares outstanding (eoy) m31.6670.45 44.9%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.60.4 142.1%   
Avg P/E ratio x516.1-1.4 -35,704.7%  
P/CF ratio (eoy) x11.8-2.6 -449.4%  
Price / Book Value ratio x0.62.1 28.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4778,067 30.7%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m562,527 2.2%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m4,21119,477 21.6%  
Other income Rs m79407 19.3%   
Total revenues Rs m4,28919,884 21.6%   
Gross profit Rs m5691,103 51.6%  
Depreciation Rs m2042,519 8.1%   
Interest Rs m4305,227 8.2%   
Profit before tax Rs m13-6,236 -0.2%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m6-125 -4.9%   
Profit after tax Rs m5-5,580 -0.1%  
Gross profit margin %13.55.7 238.5%  
Effective tax rate %48.02.0 2,392.4%   
Net profit margin %0.1-28.7 -0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85211,014 62.2%   
Current liabilities Rs m6,71132,060 20.9%   
Net working cap to sales %3.3-108.1 -3.1%  
Current ratio x1.00.3 297.2%  
Inventory Days Days16195 169.5%  
Debtors Days Days31834 949.1%  
Net fixed assets Rs m3,67329,440 12.5%   
Share capital Rs m317705 44.9%   
"Free" reserves Rs m3,7612,043 184.1%   
Net worth Rs m4,0783,800 107.3%   
Long term debt Rs m1,6719,018 18.5%   
Total assets Rs m12,63346,510 27.2%  
Interest coverage x1.0-0.2 -533.1%   
Debt to equity ratio x0.42.4 17.3%  
Sales to assets ratio x0.30.4 79.6%   
Return on assets %3.4-0.8 -453.1%  
Return on equity %0.1-146.9 -0.1%  
Return on capital %7.7-3.7 -205.5%  
Exports to sales %22.937.9 60.4%   
Imports to sales %14.322.6 63.2%   
Exports (fob) Rs m9647,378 13.1%   
Imports (cif) Rs m6024,406 13.7%   
Fx inflow Rs m9647,513 12.8%   
Fx outflow Rs m6075,649 10.7%   
Net fx Rs m3571,865 19.1%   
CASH FLOW
From Operations Rs m1,3451,682 80.0%  
From Investments Rs m-2,256-9,860 22.9%  
From Financial Activity Rs m-1,2006,644 -18.1%  
Net Cashflow Rs m-2,111-1,535 137.5%  

Share Holding

Indian Promoters % 4.5 32.3 14.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 1.4 3.3 40.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 94.1 55.3 170.2%  
Shareholders   20,807 84,811 24.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - CIPLA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS